Skip to main content
Year archive

Opthea Ltd — 2023 filings

All 108 regulatory filings released by Opthea Ltd (OPT) in 2023, sourced directly from the official regulator.

108 Filings
2023 Period
2023 filings (108)
Filing Released Lang
6-K
Regulatory Filings
2023-12-27 English
Opthea to Receive US$35M Commitment and Additional US$50M 3 pages 248.6KB
Capital/Financing Update
2023-12-26 English
Notification regarding unquoted securities - OPT 7 pages 30.0KB
Share Issue/Capital Change
2023-12-20 English
Notification regarding unquoted securities - OPT 7 pages 30.1KB
Share Issue/Capital Change
2023-12-20 English
Notification regarding unquoted securities - OPT 6 pages 28.0KB
Share Issue/Capital Change
2023-12-20 English
Change of Director's Interest Notice - MB 3 pages 250.2KB
Director's Dealing
2023-12-20 English
Change of Director's Interest Notice - AT 3 pages 248.4KB
Director's Dealing
2023-12-20 English
Change of Director's Interest Notice - LG 3 pages 249.9KB
Director's Dealing
2023-12-20 English
Change of Director's Interest Notice - JL 3 pages 248.6KB
Director's Dealing
2023-12-20 English
Opthea receives A$8.8 million R&D Tax Incentive 2 pages 166.4KB
Regulatory Filings
2023-12-19 English
6-K
Regulatory Filings
2023-12-19 English
Opthea to Present at the FLORetina 2023 Congress 2 pages 132.4KB
Regulatory Filings
2023-11-30 English
6-K
Regulatory Filings
2023-11-30 English
6-K
Regulatory Filings
2023-11-30 English
2023 AGM Chairmans Address 2 pages 166.7KB
AGM Information
2023-11-29 English
Results of Meeting 2 pages 339.5KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-29 English
Opthea presents at Jefferies 2023 Healthcare Conference 2 pages 102.4KB
Investor Presentation
2023-11-09 English
6-K
Regulatory Filings
2023-11-09 English
Opthea to present at Eyecelerator at AAO 2 pages 108.0KB
Regulatory Filings
2023-10-30 English
6-K
Regulatory Filings
2023-10-30 English
6-K
Regulatory Filings
2023-10-27 English
6-K
Regulatory Filings
2023-10-27 English
Opthea Appoints U.S. Based Leadership 6 pages 235.0KB
Board/Management Information
2023-10-26 English
Notice of Annual General Meeting/Proxy Form 94 pages 1.5MB
AGM Information
2023-10-26 English
Trading Halt 2 pages 212.6KB
Regulatory Filings
2023-10-24 English
Application for quotation of securities - OPT 6 pages 27.7KB
Share Issue/Capital Change
2023-10-12 English
Opthea to Participate at the 2023 Euretina Congress 2 pages 105.8KB
Regulatory Filings
2023-10-02 English
6-K
Regulatory Filings
2023-10-02 English
20-F
Annual Report FY 2023
2023-09-28 English
6-K
Regulatory Filings
2023-09-28 English
Opthea FY 2023 Annual Report to shareholders 104 pages 8.5MB
Annual Report FY 2023
2023-09-27 English
Opthea Appendix 4G - Corporate Governance 28 pages 1.4MB
Regulatory Filings
2023-09-27 English
Change in substantial holding 3 pages 95.0KB
Major Shareholding Notification
2023-09-24 English
Security Class Reinstatement to Quotation OPTOA 1 p
Regulatory Filings
2023-09-21 English
Opthea Announces Completion of Retail Entitlement Offer 3 pages 102.7KB
Capital/Financing Update
2023-09-20 English
Appendix 2A 23 pages 293.6KB
Regulatory Filings
2023-09-20 English
OPTOA Top Holders 2 pages 28.5KB
Major Shareholding Notification
2023-09-20 English
OPTOA - Range of Units 1 page 26.0KB
Major Shareholding Notification
2023-09-20 English
Appendix 2A update 23 pages 293.7KB
Regulatory Filings
2023-09-20 English
Security Class Suspension from Quotation OPTOA 1 pa
Regulatory Filings
2023-09-14 English
Opthea presents at H.C.Wainwright 25th Investment Conference 1
Investor Presentation
2023-09-07 English
6-K
Regulatory Filings
2023-09-07 English
Change in substantial holding 5 pages 1.6MB
Major Shareholding Notification
2023-09-05 English
Ceasing to be a substantial holder 5 pages 857.7KB
Regulatory Filings
2023-09-05 English
Ceasing to be a substantial holder 22 pages 321.5KB
Major Shareholding Notification
2023-09-05 English
Becoming a substantial holder 38 pages 1.1MB
Major Shareholding Notification
2023-09-03 English
Application for quotation of securities - OPT 6 pages 27.9KB
Capital/Financing Update
2023-08-31 English
6-K
Regulatory Filings
2023-08-31 English
Opthea Retail Entitlement Offer Opens 13 pages 599.6KB
Capital/Financing Update
2023-08-30 English
Preliminary Final Report 44 pages 523.9KB
Annual Report FY 2023
2023-08-30 English
6-K
Regulatory Filings
2023-08-28 English
Opthea completes institutional offer and increases raise 5 pages 171.1KB
Capital/Financing Update
2023-08-27 English
Update - Proposed issue of securities - OPT 13 pages 53.0KB
Capital/Financing Update
2023-08-27 English
6-K
Regulatory Filings
2023-08-24 English
Trading Halt 2 pages 212.1KB
Capital/Financing Update
2023-08-23 English
Opthea announces A$80m Capital raise 6 pages 223.3KB
Capital/Financing Update
2023-08-23 English
Opthea Investor Presentation 43 pages 3.2MB
Capital/Financing Update
2023-08-23 English
Prospectus 64 pages 426.7KB
Capital/Financing Update
2023-08-23 English
Proposed issue of securities - OPT 14 pages 54.5KB
Capital/Financing Update
2023-08-23 English
Update - Proposed issue of securities - OPT 13 pages 52.5KB
Capital/Financing Update
2023-08-23 English
Ceasing to be a substantial holder 21 pages 321.3KB
Major Shareholding Notification
2023-08-20 English
Becoming a substantial holder 42 pages 1.1MB
Major Shareholding Notification
2023-08-10 English
Ceasing to be a substantial holder 20 pages 363.0KB
Major Shareholding Notification
2023-08-08 English
Becoming a substantial holder 43 pages 1.1MB
Major Shareholding Notification
2023-08-02 English
6-K
Regulatory Filings
2023-08-01 English
ASRS 2023 - PK and safety of sozinibercept (OPT-302) 12 pages 1.7MB
Investor Presentation
2023-07-31 English
OPT Announces Sozinibercept as the Drug Name for OPT 302 2 pages 100.0KB
Regulatory Filings
2023-07-26 English
6-K
Regulatory Filings
2023-07-26 English
Opthea Presents at the 2023 Ophthalmology Innovation Summit 2 pages 133.1KB
Investor Presentation
2023-07-24 English
6-K
Regulatory Filings
2023-07-24 English
Opthea to Feature at the ASRS 2023 Annual Meeting 2 pages 122.3KB
Regulatory Filings
2023-07-13 English
6-K
Regulatory Filings
2023-07-13 English
Opthea Announces Appointment of Snr Medical Advisor 2 pages 104.0KB
Board/Management Information
2023-07-10 English
6-K
Regulatory Filings
2023-07-10 English
Change in substantial holding 4 pages 96.4KB
Major Shareholding Notification
2023-06-22 English
Opthea Appoints Anshul Thakral as Non-Executive Director 2 pages 136.9KB
Board/Management Information
2023-06-08 English
Initial Director's Interest Notice AT 2 pages 213.1KB
Director's Dealing
2023-06-08 English
Final Director's Interest Notice MS 2 pages 284.3KB
Director's Dealing
2023-06-08 English
6-K
Regulatory Filings
2023-06-08 English
Ceasing to be a substantial holder 4 pages 170.4KB
Major Shareholding Notification
2023-06-01 English
Opthea Presents at the Jefferies 2023 Healthcare Conference 2 pages 133.3KB
Investor Presentation
2023-05-25 English
6-K
Regulatory Filings
2023-05-25 English
Opthea participates in EF Hutton hosted webinar on OPT-302 2 pages 132.6KB
Regulatory Filings
2023-05-17 English
6-K
Regulatory Filings
2023-05-17 English
Change in substantial holding 9 pages 279.6KB
Major Shareholding Notification
2023-05-16 English
Opthea Presents at JMP Securities Life Sciences Conference 2 pages 152.8KB
Investor Presentation
2023-05-08 English
6-K
Regulatory Filings
2023-05-08 English
6-K
Regulatory Filings
2023-04-28 English
Opthea to Participate at HC Wainwright BioConnect Conference 1
Capital/Financing Update
2023-04-27 English
Becoming a substantial holder 13 pages 230.2KB
Major Shareholding Notification
2023-03-19 English
6-K
Regulatory Filings
2023-03-07 English
Opthea to participate at Oppenheimer's Healthcare Conference 2 pages 139.7KB
Investor Presentation
2023-03-06 English
Opthea Receives A$8.7million R&D Tax Incentive 2 pages 164.7KB
Capital/Financing Update
2023-03-06 English
6-K
Regulatory Filings
2023-03-06 English
6-K
Regulatory Filings
2023-02-23 English
Half Year Accounts 34 pages 1.4MB
Interim / Quarterly Report H1 2023
2023-02-22 English
Response to ASX Query 6 pages 323.6KB
Regulatory Filings
2023-02-15 English
FORM SC 13G/A
Major Shareholding Notification
2023-02-15 English
SC 13G/A
Major Shareholding Notification
2023-02-14 English
Opthea Ph2b Trial Results with OPT-302 published in Journal 2 pages 108.5KB
Regulatory Filings
2023-02-13 English
6-K
Regulatory Filings
2023-02-13 English
Appendix 2A 20 pages 605.2KB
Regulatory Filings
2023-02-09 English
Opthea to present at SVB Leerink Global Biopharma Conference 2 pages 143.7KB
Investor Presentation
2023-02-06 English
6-K
Regulatory Filings
2023-02-06 English
Opthea to Present at Sequire Biotechnology Conference 2 pages 99.2KB
Investor Presentation
2023-01-30 English
6-K
Regulatory Filings
2023-01-30 English
6-K
Regulatory Filings
2023-01-11 English
Opthea Corporate Presentation - San Francisco Jan 2023 27 pages 1.2MB
Investor Presentation
2023-01-10 English